Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Seven year long follow-up of patient with childhood chronic myeloid leukemia postsecond haploidentical stem cell transplant (Sachdev M et al. J Pediatr Hematol Oncol, November 2021)

Seven year long follow-up of patient with childhood chronic myeloid leukemia postsecond haploidentical stem cell transplant
Sachdev M et al. J Pediatr Hematol Oncol, November 2021

Link to full abstract

 

 

Pediatric chronic myeloid leukemia presenting with extreme thrombocytosis and acute upper gastrointestinal haemorrhage: A case report (Zhang Y et al. J Pediatr Hematol Oncol, Oct 2021)

Pediatric chronic myeloid leukemia presenting with extreme thrombocytosis and acute upper gastrointestinal haemorrhage: A case report
Zhang Y et al. J Pediatr Hematol Oncol, October 2021

Link to full abstract

 

 

Discontinuation of imatinib in children with chronic myeloid leukemia: A study from the International Registry of Childhood CML (Millot F et al. Cancers(Basel), August 2021

Discontinuation of imatinib in children with chronic myeloid leukemia: A study from the International Registry of childhood CML
Millot F et al. Cancers(Basel), August 2021 – open access publication

Link to full abstract

 

 

Chronic myeloid leukemia in children: immune function and vaccinations (Suttorp M et al. J Clin Med, September 2021)

Chronic myeloid leukemia in children: immune functions and vaccinations
Suttorp M et al. J Clin Med, September 2021 – open access publication

Link to full abstract

 

 

A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety

A phase 2 study of nilotinib in pediatric patients with CML: Long-term update on growth retardation and safety
Hijiya N et al. Blood Adv, July 2021 (epub ahead of print) - open access publication

Link to full abstract

 

 

  1. Adolescents experienced more treatment failure than children with CML receiving imatinib as frontline therapy: a retrospective multicentre study (Dou X et al. Ann Hematol, June 2021)
  2. Sudden blast phase in paediatric chronic myeloid leukemia-chronic phase with abnormal blasts detected by flow cytometry at diagnosis. Can it be considered a warning sign? (Vijayasekharan K et al. Cytometry B Clin Cymtom, May 2021)
  3. Tyrosine kinase inhibitors and beyond for chronic myeloid leukemia in children (Phillips LN and Hijiya N. Paediatr Drug, April 2021)
  4. Paediatric chronic myeloid leukemia presenting in de novo or secondary blast phase – a comparison of clinical and genetic characteristics (Sembill S et al. Br J Haematol, March 2021)